Li J, Vinh DC, Casanova JL, Puel A. Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals. Curr Opin Microbiol. 2017;40:46–57.
Article CAS PubMed PubMed Central Google Scholar
Benedict K, Richardson M, Vallabhaneni S, Jackson BR, Chiller T. Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. Lancet Infect Dis. 2017;17(12):e403–11.
Article PubMed PubMed Central Google Scholar
Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13.
Pilmis B, Puel A, Lortholary O, Lanternier F. New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect. 2016;22(8):681–7.
Article CAS PubMed Google Scholar
Lionakis MS. Primary immunodeficiencies and invasive fungal infection: when to suspect and how to diagnose and manage. Curr Opin Infect Dis. 2019;32(6):531–7.
Escandon P, Lizarazo J, Agudelo CI, Castaneda E. Cryptococcosis in Colombia: compilation and analysis of data from laboratory-based surveillance. J Fungi (Basel). 2018;4(1):32.
Lizarazo J, Linares M, de Bedout C, Restrepo A, Agudelo CI, Castaneda E, et al. Results of nine years of the clinical and epidemiological survey on cryptococcosis in Colombia, 1997–2005. Biomedica. 2007;27(1):94–109.
Puel A, Bastard P, Bustamante J, Casanova JL. Human autoantibodies underlying infectious diseases. J Exp Med. 2022;219(4):e20211387.
Boisson-Dupuis S, Bustamante J. Mycobacterial diseases in patients with inborn errors of immunity. Curr Opin Immunol. 2021;72:262–71.
Article CAS PubMed PubMed Central Google Scholar
Rosain J, Neehus A-L, Manry J, Yang R, Le Pen J, Daher W et al. Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria. Cell. 2023;186(3):621–645.e33 S0092867422015811. https://doi.org/10.1016/j.cell.2022.12.038
Puel A, Picard C, Lorrot M, Pons C, Chrabieh M, Lorenzo L, et al. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol. 2008;180(1):647–54.
Article CAS PubMed Google Scholar
Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–1507.
Levy R, Langlais D, Beziat V, Rapaport F, Rao G, Lazarov T, et al. Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents. J Clin Invest. 2021;131(17):e150143.
Puel A. Human inborn errors of immunity underlying superficial or invasive candidiasis. Hum Genet. 2020;139(6–7):1011–22.
Article PubMed PubMed Central Google Scholar
Philippot Q, Ogishi M, Bohlen J, Puchan J, Arias AA, Nguyen T et al. Human IL-23 is essential for IFN-γ–dependent immunity to mycobacteria. Sci Immun. 2023;8(80):eabq5204. https://doi.org/10.1126/sciimmunol.abq5204
Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4585.
Bastard P, Michailidis E, Hoffmann HH, Chbihi M, Le Voyer T, Rosain J, et al. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J Exp Med. 2021;218(4):e20202486.
Zhang Q, Pizzorno A, Miorin L, Bastard P, Gervais A, Voyer TL et al. Autoantibodies against type I IFNs in patients with critical influenza pneumonia. J Exp Med. 2022;219(11):e20220514. https://doi.org/10.1084/jem.20220514
Ansari R, Rosen LB, Lisco A, Gilden D, Holland SM, Zerbe CS et al. Primary and acquired immunodeficiencies associated with severe varicella-zoster virus infections. Clin Infect Dis. 2021;73(9):e2705–e2712. https://doi.org/10.1093/cid/ciaa1274
Zhang Q, Bastard P, Effort CHG, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603(7902):587–98.
Article CAS PubMed PubMed Central Google Scholar
Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16.
Punatar AD, Kusne S, Blair JE, Seville MT, Vikram HR. Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infect. 2012;65(2):173–9.
Kuo CY, Wang SY, Shih HP, Tu KH, Huang WC, Ding JY, et al. Disseminated cryptococcosis due to anti-granulocyte-macrophage colony-stimulating factor autoantibodies in the absence of pulmonary alveolar proteinosis. J Clin Immunol. 2017;37(2):143–52.
Article CAS PubMed Google Scholar
Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, et al. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. mBio. 2014;5(2):e00912-14.
Article PubMed PubMed Central Google Scholar
Rosen LB, Freeman AF, Yang LM, Jutivorakool K, Olivier KN, Angkasekwinai N, et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol. 2013;190(8):3959–66.
Article CAS PubMed Google Scholar
Rosen LB, Rocha Pereira N, Figueiredo C, Fiske LC, Ressner RA, Hong JC, et al. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis. Clin Infect Dis. 2015;60(7):1017–25.
Article CAS PubMed Google Scholar
Salvator H, Cheng A, Rosen LB, Williamson PR, Bennett JE, Kashyap A et al. Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis cryptococcal meningitis and severe nocardiosis. Resp Res. 2022;23(1):280. https://doi.org/10.1186/s12931-022-02103-9
Zhan Y, Xu Y, Lew AM. The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor. Mol Immunol. 2012;52(1):30–7.
Article CAS PubMed Google Scholar
Becher B, Tugues S, Greter M. GM-CSF: from growth factor to central mediator of tissue inflammation. Immunity. 2016;45(5):963–73.
Article CAS PubMed Google Scholar
Robb L, Drinkwater CC, Metcalf D, Li R, Kontgen F, Nicola NA, et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A. 1995;92(21):9565–9.
Article CAS PubMed PubMed Central Google Scholar
LeVine AM, Reed JA, Kurak KE, Cianciolo E, Whitsett JA. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J Clin Invest. 1999;103(4):563–9.
Article CAS PubMed PubMed Central Google Scholar
Chen GH, Teitz-Tennenbaum S, Neal LM, Murdock BJ, Malachowski AN, Dils AJ, et al. Local GM-CSF-dependent differentiation and activation of pulmonary dendritic cells and macrophages protect against progressive cryptococcal lung infection in mice. J Immunol. 2016;196(4):1810–21.
Article CAS PubMed Google Scholar
Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010;135(2):223–35.
Article CAS PubMed PubMed Central Google Scholar
Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med. 1999;190(6):875–80.
Article CAS PubMed PubMed Central Google Scholar
Demir S, Chebib N, Thivolet-Bejui F, Cottin V. Pulmonary alveolar proteinosis following cryptococcal meningitis: a possible cause? BMJ Case Rep. 2018;2018:bcr2017222940.
Quah J, Low TB, Fong R. Disseminated Cryptococcus gattii infection preceding onset of pulmonary alveolar proteinosis. Respirol Case Rep. 2018;6(7):e00357.
Bryson BD, Rosebrock TR, Tafesse FG, Itoh CY, Nibasumba A, Babunovic GH, et al. Heterogeneous GM-CSF signaling in macrophages is associated with control of Mycobacterium tuberculosis. Nat Commun. 2019;10(1):2329.
Article PubMed PubMed Central Google Scholar
Rothchild AC, Stowell B, Goyal G, Nunes-Alves C, Yang Q, Papavinasasundaram K, et al. Role of granulocyte-macrophage colony-stimulating factor production by T cells during Mycobacterium tuberculosis Infection. mBio. 2017;8(5):e01514–17.
Gonzalez-Juarrero M, Hattle JM, Izzo A, Junqueira-Kipnis AP, Shim TS, Trapnell BC, et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol. 2005;77(6):914–22.
Article CAS PubMed Google Scholar
Vogt G, Nathan C. In vitro differentiation of human macrophages with enhanced antimycobacterial activity. J Clin Invest. 2011;121(10):3889–901.
Article CAS PubMed PubMed Central Google Scholar
Chi CY, Chu CC, Liu JP, Lin CH, Ho MW, Lo WJ, et al. Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121(8):1357–66.
Article CAS PubMed Google Scholar
Sakaue S, Yamaguchi E, Inoue Y, Takahashi M, Hirata J, Suzuki K, et al. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis. Nat Commun. 2021;12(1):1032.
Article CAS PubMed PubMed Central Google Scholar
Anderson K, Carey B, Martin A, Roark C, Chalk C, Nowell-Bostic M, et al. Pulmonary alveolar proteinosis: an autoimmune disease lacking an HLA association. PLoS ONE. 2019;14(3):e0213179.
留言 (0)